DermaVir Patch (HIV DNA vaccine topical)
/ Genetic Immunity, National Institute of Allergy and Infectious Diseases
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
September 16, 2025
Preparation Uniform Thin Tubular Carbon Nanofiber Using Novel Bimetallic Catalyst at Low Temperature and Its Structural Feature.
(PubMed, ACS Omega)
- "The specific amount of Mn 70 wt % on the Fe-Mn catalyst was key for the selective preparation of uniform duplicated CNFs with an aligned tubular graphene structure. The obtained TCNFs had relatively high graphitic property; the interlayer spacing (d 002) and the stacking height Lc(002) were 5.4 nm, respectively, because of the unique duplicated morphology."
Journal
July 28, 2024
The Phylogeny and Metabolic Potentials of an Aromatics-Degrading Marivivens Bacterium Isolated from Intertidal Seawater in East China Sea.
(PubMed, Microorganisms)
- "For sulfur assimilation, it employs various pathways to utilize organic and inorganic substrates, including the SOX system and DSMP utilization. Overall, LCG002's metabolic versatility and genetic profile contribute to its ecological significance in marine environments, particularly in the degradation of lignocellulosic material and aromatic monomers."
Journal
April 09, 2023
Isolation of lectin from Musa acuminata for its antibiofilm potential against Methicillin-resistant Staphylococcus aureus and its synergistic effect with Enterococcus species.
(PubMed, Arch Microbiol)
- "The CFS of Enterococcus faecium (LCM002), Enterococcus lactis (LCM003) and Enterococcus durans (LCM004 and LCM005) displayed antagonistic effects against pathogen...This study demonstrates the use of Enterococcus species and plant proteins against pathogens and results suggested that it can inhibit the growth of resistant strains of Staphylococcus aureus and their synergistic effect has opened new ways to tackle emerging resistance. Furthermore, after assessment of Enterococcus as probiotics, this could be used in food industries as well as in treatment of severe skin infections."
Journal • Dermatology • Infectious Disease
March 01, 2021
"Real Help, Live Up to It! AGT103-T Vacc-C5, Vacc-4x, Pro140, OyaGen HIV eradication, eCD4-Ig Farzan protein, FIT Biotech(now disappeared), Dermavir, N6 antibody, VRC01, SP-01A, VDA KP-1461 Mosaico Ragon institute block n lock gene deserts moved toward vaccine elite control"
(@FernandAubry)
Human Immunodeficiency Virus • Infectious Disease • CD4
February 22, 2020
"Vacc-C5, Vacc-4x, Pro140, OyaGen HIV eradication, eCD4-Ig Farzan protein, FIT Biotech(now disappeared), Dermavir, N6 antibody, VRC01, SP-01A, VDA KP-1461 just to name a few. So honor history in the present!"
(@beautyhero1)
January 28, 2020
GIEU006: Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients
(clinicaltrials.gov)
- P2; N=36; Completed; Sponsor: Genetic Immunity; Active, not recruiting ➔ Completed
Trial completion
December 03, 2019
"Vacc-C5, Vacc-4x, Pro140, OyaGen HIV eradication, eCD4-Ig Farzan protein, FIT Biotech(now disappeared), Dermavir, N6 antibody, VRC01, SP-01A, VDA KP-1461 just to name a few. So are you serious or just playing propaganda?"
(@beautyhero1)
November 29, 2019
"Vacc-C5, Vacc-4x, Pro140, OyaGen HIV eradication, eCD4-Ig Farzan protein, FIT Biotech(now disappeared), Dermavir, N6 antibody, VRC01, SP-01A, VDA KP-1461 just to name a few. So are you serious or just playing propaganda? CURE NOW or shut up Gilead!"
(@beautyhero1)
1 to 8
Of
8
Go to page
1